CN111758781A - Milk powder beneficial to promoting height development and preparation method thereof - Google Patents
Milk powder beneficial to promoting height development and preparation method thereof Download PDFInfo
- Publication number
- CN111758781A CN111758781A CN202010657603.4A CN202010657603A CN111758781A CN 111758781 A CN111758781 A CN 111758781A CN 202010657603 A CN202010657603 A CN 202010657603A CN 111758781 A CN111758781 A CN 111758781A
- Authority
- CN
- China
- Prior art keywords
- parts
- milk powder
- vitamin
- sulfate
- oligosaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 142
- 235000013336 milk Nutrition 0.000 title claims abstract description 87
- 239000008267 milk Substances 0.000 title claims abstract description 87
- 210000004080 milk Anatomy 0.000 title claims abstract description 87
- 230000001737 promoting effect Effects 0.000 title claims abstract description 38
- 230000009286 beneficial effect Effects 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims abstract description 75
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 63
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 52
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 50
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 50
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims abstract description 49
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 48
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims abstract description 40
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000011575 calcium Substances 0.000 claims abstract description 38
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 38
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 32
- 229960002477 riboflavin Drugs 0.000 claims abstract description 32
- 235000008939 whole milk Nutrition 0.000 claims abstract description 32
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims abstract description 31
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims abstract description 31
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims abstract description 31
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims abstract description 31
- 235000019192 riboflavin Nutrition 0.000 claims abstract description 31
- 239000002151 riboflavin Substances 0.000 claims abstract description 31
- 210000002969 egg yolk Anatomy 0.000 claims abstract description 30
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims abstract description 29
- 210000003022 colostrum Anatomy 0.000 claims abstract description 29
- 235000021277 colostrum Nutrition 0.000 claims abstract description 29
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 28
- 229960003080 taurine Drugs 0.000 claims abstract description 26
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims abstract description 25
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims abstract description 25
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims abstract description 25
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 25
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 25
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 25
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 25
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 25
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims abstract description 25
- 229940009289 bifidobacterium lactis Drugs 0.000 claims abstract description 25
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims abstract description 25
- 239000001506 calcium phosphate Substances 0.000 claims abstract description 25
- 229910000365 copper sulfate Inorganic materials 0.000 claims abstract description 25
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims abstract description 25
- MHJAJDCZWVHCPF-UHFFFAOYSA-L dimagnesium phosphate Chemical compound [Mg+2].OP([O-])([O-])=O MHJAJDCZWVHCPF-UHFFFAOYSA-L 0.000 claims abstract description 25
- 229910000395 dimagnesium phosphate Inorganic materials 0.000 claims abstract description 25
- 229940090949 docosahexaenoic acid Drugs 0.000 claims abstract description 25
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 25
- 239000011790 ferrous sulphate Substances 0.000 claims abstract description 25
- 235000003891 ferrous sulphate Nutrition 0.000 claims abstract description 25
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 25
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 25
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 25
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 25
- 229960000367 inositol Drugs 0.000 claims abstract description 25
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims abstract description 25
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims abstract description 25
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims abstract description 25
- 239000008101 lactose Substances 0.000 claims abstract description 25
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 25
- 229940099596 manganese sulfate Drugs 0.000 claims abstract description 25
- 239000011702 manganese sulphate Substances 0.000 claims abstract description 25
- 235000007079 manganese sulphate Nutrition 0.000 claims abstract description 25
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims abstract description 25
- 239000001103 potassium chloride Substances 0.000 claims abstract description 25
- 235000011164 potassium chloride Nutrition 0.000 claims abstract description 25
- 239000001508 potassium citrate Substances 0.000 claims abstract description 25
- 229960002635 potassium citrate Drugs 0.000 claims abstract description 25
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims abstract description 25
- 235000011082 potassium citrates Nutrition 0.000 claims abstract description 25
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000011780 sodium chloride Substances 0.000 claims abstract description 25
- 235000012424 soybean oil Nutrition 0.000 claims abstract description 25
- 239000003549 soybean oil Substances 0.000 claims abstract description 25
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 25
- 229940078499 tricalcium phosphate Drugs 0.000 claims abstract description 25
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims abstract description 25
- 235000019731 tricalcium phosphate Nutrition 0.000 claims abstract description 25
- 235000021119 whey protein Nutrition 0.000 claims abstract description 25
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims abstract description 25
- 229960001763 zinc sulfate Drugs 0.000 claims abstract description 25
- 229910000368 zinc sulfate Inorganic materials 0.000 claims abstract description 25
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims abstract description 23
- 235000019743 Choline chloride Nutrition 0.000 claims abstract description 23
- 239000002211 L-ascorbic acid Substances 0.000 claims abstract description 23
- 235000000069 L-ascorbic acid Nutrition 0.000 claims abstract description 23
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 23
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims abstract description 23
- 229960003178 choline chloride Drugs 0.000 claims abstract description 23
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 22
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims abstract description 20
- 235000010265 sodium sulphite Nutrition 0.000 claims abstract description 20
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract description 19
- 235000007715 potassium iodide Nutrition 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 18
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims abstract description 16
- 239000011740 D-alpha-tocopherylacetate Substances 0.000 claims abstract description 14
- 235000002414 D-alpha-tocopherylacetate Nutrition 0.000 claims abstract description 14
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940039770 d-alpha-tocopheryl acetate Drugs 0.000 claims abstract description 14
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 12
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 12
- 229960003495 thiamine Drugs 0.000 claims abstract description 12
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims abstract description 12
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims abstract description 12
- 239000011647 vitamin D3 Substances 0.000 claims abstract description 12
- 235000005282 vitamin D3 Nutrition 0.000 claims abstract description 12
- 229940021056 vitamin d3 Drugs 0.000 claims abstract description 12
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 11
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000019152 folic acid Nutrition 0.000 claims abstract description 11
- 239000011724 folic acid Substances 0.000 claims abstract description 11
- 229960000304 folic acid Drugs 0.000 claims abstract description 11
- 235000019157 thiamine Nutrition 0.000 claims abstract description 11
- 239000011721 thiamine Substances 0.000 claims abstract description 11
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000004519 grease Substances 0.000 claims abstract description 10
- 239000011769 retinyl palmitate Substances 0.000 claims abstract description 10
- 229940108325 retinyl palmitate Drugs 0.000 claims abstract description 10
- 235000019172 retinyl palmitate Nutrition 0.000 claims abstract description 10
- 229960005069 calcium Drugs 0.000 claims abstract description 8
- 229960000355 copper sulfate Drugs 0.000 claims abstract description 8
- 229960001781 ferrous sulfate Drugs 0.000 claims abstract description 8
- 229960002816 potassium chloride Drugs 0.000 claims abstract description 8
- 229960004839 potassium iodide Drugs 0.000 claims abstract description 8
- 229940001482 sodium sulfite Drugs 0.000 claims abstract description 8
- -1 phytotoluquinone Chemical compound 0.000 claims abstract description 5
- 235000017060 Arachis glabrata Nutrition 0.000 claims abstract description 4
- 244000105624 Arachis hypogaea Species 0.000 claims abstract description 4
- 235000010777 Arachis hypogaea Nutrition 0.000 claims abstract description 4
- 235000018262 Arachis monticola Nutrition 0.000 claims abstract description 4
- 235000020232 peanut Nutrition 0.000 claims abstract description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 44
- 239000003921 oil Substances 0.000 claims description 38
- 235000019198 oils Nutrition 0.000 claims description 38
- 239000011259 mixed solution Substances 0.000 claims description 28
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 24
- 235000021342 arachidonic acid Nutrition 0.000 claims description 22
- 229940114079 arachidonic acid Drugs 0.000 claims description 22
- 150000002148 esters Chemical class 0.000 claims description 18
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 16
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 16
- 229930003316 Vitamin D Natural products 0.000 claims description 16
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 16
- 235000019155 vitamin A Nutrition 0.000 claims description 16
- 239000011719 vitamin A Substances 0.000 claims description 16
- 235000019166 vitamin D Nutrition 0.000 claims description 16
- 239000011710 vitamin D Substances 0.000 claims description 16
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 16
- 229940045997 vitamin a Drugs 0.000 claims description 16
- 229940046008 vitamin d Drugs 0.000 claims description 16
- 238000005469 granulation Methods 0.000 claims description 14
- 230000003179 granulation Effects 0.000 claims description 14
- 239000002245 particle Substances 0.000 claims description 14
- 239000007921 spray Substances 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 14
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 12
- 235000008160 pyridoxine Nutrition 0.000 claims description 12
- 239000011677 pyridoxine Substances 0.000 claims description 12
- 229940011671 vitamin b6 Drugs 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- 238000007580 dry-mixing Methods 0.000 claims description 7
- 238000000265 homogenisation Methods 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 6
- 235000021314 Palmitic acid Nutrition 0.000 claims description 6
- ONJIBHRZSUEBDS-UHFFFAOYSA-N azane;pyridine-3-carboxylic acid Chemical compound [NH4+].[O-]C(=O)C1=CC=CN=C1 ONJIBHRZSUEBDS-UHFFFAOYSA-N 0.000 claims description 6
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 6
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 claims description 6
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 claims description 4
- 229960002218 sodium chlorite Drugs 0.000 claims description 4
- 239000001707 (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol Substances 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 3
- BLUHKGOSFDHHGX-UHFFFAOYSA-N Phytol Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C=CO BLUHKGOSFDHHGX-UHFFFAOYSA-N 0.000 claims description 3
- HNZBNQYXWOLKBA-UHFFFAOYSA-N Tetrahydrofarnesol Natural products CC(C)CCCC(C)CCCC(C)=CCO HNZBNQYXWOLKBA-UHFFFAOYSA-N 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 3
- BOTWFXYSPFMFNR-OALUTQOASA-N all-rac-phytol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)=CCO BOTWFXYSPFMFNR-OALUTQOASA-N 0.000 claims description 3
- 235000019270 ammonium chloride Nutrition 0.000 claims description 3
- LRIHKZMLMWYPFS-UHFFFAOYSA-N azanium;hexadecanoate Chemical compound [NH4+].CCCCCCCCCCCCCCCC([O-])=O LRIHKZMLMWYPFS-UHFFFAOYSA-N 0.000 claims description 3
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 claims description 3
- 229940081066 picolinic acid Drugs 0.000 claims description 3
- 125000002523 retinol group Chemical group 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- TXUDGGAHAIBEIW-UHFFFAOYSA-N S(=O)(=O)([O-])[O-].C(C1=CN=CC=C1)(=O)[O-].[NH4+].[NH4+].[NH4+] Chemical compound S(=O)(=O)([O-])[O-].C(C1=CN=CC=C1)(=O)[O-].[NH4+].[NH4+].[NH4+] TXUDGGAHAIBEIW-UHFFFAOYSA-N 0.000 claims description 2
- 229940042585 tocopherol acetate Drugs 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 239000002253 acid Substances 0.000 abstract description 3
- 230000018109 developmental process Effects 0.000 description 26
- 230000012010 growth Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 230000009102 absorption Effects 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 235000013345 egg yolk Nutrition 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 210000000963 osteoblast Anatomy 0.000 description 3
- 210000002997 osteoclast Anatomy 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000008468 bone growth Effects 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 235000020803 food preference Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
- 229910000861 Mg alloy Inorganic materials 0.000 description 1
- LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 1
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- ZQBZAOZWBKABNC-UHFFFAOYSA-N [P].[Ca] Chemical compound [P].[Ca] ZQBZAOZWBKABNC-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 229940085298 biotin 10 mg Drugs 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 230000014461 bone development Effects 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229940069978 calcium supplement Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940033203 vitamin b6 0.5 mg Drugs 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/154—Milk preparations; Milk powder or milk powder preparations containing additives containing thickening substances, eggs or cereal preparations; Milk gels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses milk powder beneficial to promoting height development and a preparation method thereof, and relates to the technical field of milk powder production, wherein the milk powder comprises the following raw material components: the feed comprises whole milk powder, lactose, colostrum basic protein, hydrolyzed yolk powder, soybean oil, fructo-oligosaccharide, galacto-oligosaccharide, bifidobacterium lactis, maltodextrin, concentrated whey protein powder, potassium citrate, tricalcium phosphate, potassium chloride, magnesium hydrogen phosphate, sodium chloride, milk calcium, ferrous sulfate, zinc sulfate, copper sulfate, manganese sulfate, potassium iodide, sodium sulfite, choline chloride, L-ascorbic acid, ascorbyl palmitate, D-alpha-tocopheryl acetate, inositol, D-calcium pantothenate, nicotinamide, riboflavin, thiamine nicotinate, vitamin A palmitate, pyridoxine hydrochloride, folic acid, phytotoluquinone, vitamin D3, docosahexaenoic acid oleoyl ester, peanut tetradilute acid grease, taurine and edible essence.
Description
Technical Field
The invention relates to the technical field of milk powder production, in particular to milk powder beneficial to promoting height development and a preparation method thereof.
Background
Of the various developmental stages of humans, age 3-17 is the peak stage of development in children, where children often fail to meet the basic nutrients in their growth and development due to food preferences, food preferences and anorexia.
At present, the child milk powder on the market is prepared by a dry process or a wet process, and the dry process can cause milk freshness and nutrition loss in the preparation process; the activity of heat-sensitive nutrients is easily reduced in the low-temperature spraying process by the wet process.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides milk powder beneficial to promoting the growth and development of the height and a preparation method thereof.
The milk powder comprises the following raw material components in parts by weight: 380 portions of whole milk powder, 420 portions of milk powder, 4 to 6 portions of lactose, 0.6 to 1 portion of colostrum basic protein, 0.8 to 1.2 portions of hydrolyzed yolk powder, 0.8 to 1.2 portions of soybean oil, 1.8 to 2.2 portions of fructo-oligosaccharide, 2.8 to 3.2 portions of galacto-oligosaccharide, 2 to 4 portions of bifidobacterium lactis, 0.04 to 0.06 portion of maltodextrin, 8 to 12 portions of concentrated whey protein powder, 0.05 to 0.07 portion of potassium citrate, 0.8 to 1.2 portions of tricalcium phosphate, 0.07 to 0.09 portion of potassium chloride, 0.03 to 0.05 portion of magnesium hydrogen phosphate, 0.03 to 0.05 portion of sodium chloride, 0.8 to 1.2 portions of milk calcium, 0.8 to 1.2 portion of ferrous sulfate, 0.8 to 1.2 portions of zinc sulfate, 0.7 to 1.1 portion of copper sulfate, 0.6 to 1 portion of manganese sulfate, 0.7 to 1 portion of potassium iodide, 0.7 to 1.1 portion of sodium chlorite, 0.07 to 0.06 portion of sodium chlorite, 0.09 to 0.07 portion of L-1 portion of L-L, 0.08-0.10 part of ascorbyl palmitate, 0.02-0.04 part of D-alpha-tocopherol acetate, 0.008-0.012 part of inositol, 0.8-1.2 part of D-calcium pantothenate, 0.5-0.7 part of nicotinamide, 0.7-1.1 part of riboflavin, 0.008-0.012 part of ammonium nicotinate sulfate, 0.8-1.2 part of vitamin A palmitate, 0.03-0.05 part of pyridoxine hydrochloride, 0.05-0.07 part of folic acid, 0.06-0.08 part of phytotoluquinone, 30.7-1.1 part of vitamin D, 0.7-1.1 part of docosahexaenoic acid oil ester, 0.7-1.1 part of peanut tetraol, 0.8-1.2 part of taurine and 0.8-1.2 part of edible essence.
Preferably, the milk powder comprises the following raw material components in parts by weight: 380 parts of whole milk powder, 4 parts of lactose, 0.6 part of colostrum basic protein, 0.8 part of hydrolyzed yolk powder, 0.8 part of soybean oil, 1.8 parts of fructo-oligosaccharide, 2.8 parts of galacto-oligosaccharide, 2 parts of bifidobacterium lactis, 0.04 part of maltodextrin, 8 parts of concentrated whey protein powder, 0.05 part of potassium citrate, 0.8 part of tricalcium phosphate, 0.07 part of potassium chloride, 0.03 part of magnesium hydrogen phosphate, 0.03 part of sodium chloride, 0.8 part of milk calcium, 0.8 part of ferrous sulfate, 0.8 part of zinc sulfate, 0.7 part of copper sulfate, 0.6 part of manganese sulfate, 0.7 part of potassium iodide, 0.07 part of sodium sulfite, 0.06 part of choline chloride, 0.07 part of L-ascorbic acid, 0.08 part of ascorbyl palmitate, 0.02 part of D-alpha-tocopheryl acetate, 0.008 part of inositol, 0.8 part of D-calcium pantothenate, 0.5 part of nicotinamide, 0.7 part of riboflavin, 0.008 part of ammonium nicotinate, 0.03 part of ammonium palmitate, 0.05 part of pyridoxine hydrochloride, 0.05 part of phytol, 30.7 parts of vitamin D, 0.7 part of docosahexaenoic acid oil ester, 0.7 part of arachidonic acid grease, 0.8 part of taurine and 0.8 part of edible essence.
Preferably, the milk powder comprises the following raw material components in parts by weight: 390 parts of whole milk powder, 4.5 parts of lactose, 0.7 part of colostrum basic protein, 0.9 part of hydrolyzed yolk powder, 0.9 part of soybean oil, 1.9 parts of fructo-oligosaccharide, 2.9 parts of galacto-oligosaccharide, 2.5 parts of bifidobacterium lactis, 0.045 part of maltodextrin, 9 parts of concentrated whey protein powder, 0.055 part of potassium citrate, 0.9 part of tricalcium phosphate, 0.075 part of potassium chloride, 0.035 part of magnesium hydrogen phosphate, 0.035 part of sodium chloride, 0.9 part of milk calcium, 0.9 part of ferrous sulfate, 0.9 part of zinc sulfate, 0.8 part of copper sulfate, 0.7 part of manganese sulfate, 0.8 part of potassium iodide, 0.075 part of sodium subsp, 0.065 part of choline chloride, 0.075 part of L-ascorbic acid, 0.085 part of ascorbyl palmitate, 0.025 part of D-alpha-phenol acetate, 0.009 part of inositol, 0.9 part of D-calcium pantothenate, 0.0655 part of riboflavin, 0.8 part of riboflavin, 0.009 part of picolinic acid, 0.009 part of pyridoxine, 0.009 part of vitamin A, 0.055 part of vitamin A, pyridoxine hydrochloride, 0.035 parts of pyridoxine hydrochloride, 0.055 part of vitamin A, 30.8 parts of vitamin D, 0.8 part of docosahexaenoic acid oil ester, 0.8 part of arachidonic acid grease, 0.9 part of taurine and 0.9 part of edible essence.
Preferably, the milk powder comprises the following raw material components in parts by weight: 400 parts of whole milk powder, 5 parts of lactose, 0.8 part of colostrum basic protein, 1 part of hydrolyzed yolk powder, 1 part of soybean oil, 2 parts of fructo-oligosaccharide, 3 parts of galacto-oligosaccharide, 3 parts of bifidobacterium lactis, 0.05 part of maltodextrin, 10 parts of concentrated whey protein powder, 0.06 part of potassium citrate, 1 part of tricalcium phosphate, 0.08 part of potassium chloride, 0.04 part of magnesium hydrogen phosphate, 0.04 part of sodium chloride, 1 part of milk calcium, 1 part of ferrous sulfate, 1 part of zinc sulfate, 0.9 part of copper sulfate, 0.8 part of manganese sulfate, 0.9 part of potassium iodide, 0.08 part of sodium sulfite, 0.07 part of choline chloride, 0.08 part of L-ascorbic acid, 0.09 part of ascorbyl palmitate, 0.03 part of D-alpha-acetic acid phenol, 0.01 part of inositol, 1 part of D-calcium pantothenate, 0.6 part of nicotinamide, 0.9 part of riboflavin, 0.01 part of thiamine, 0.06 part of vitamin A1 part of palmitic acid, 0.04 part of pyridoxine hydrochloride, 0.07 part of phytochrome nicotinate, 0.07 part of pyridoxine, 30.9 parts of vitamin D, 0.9 part of docosahexaenoic acid oil ester, 0.9 part of arachidonic acid oil, 1 part of taurine and 1 part of edible essence.
Preferably, the milk powder comprises the following raw material components in parts by weight: 410 parts of whole milk powder, 5.5 parts of lactose, 0.9 part of colostrum basic protein, 1.1 part of hydrolyzed yolk powder, 1.1 parts of soybean oil, 2.1 parts of fructo-oligosaccharide, 3.1 parts of galacto-oligosaccharide, 3.5 parts of bifidobacterium lactis, 0.055 part of maltodextrin, 11 parts of concentrated whey protein powder, 0.065 part of potassium citrate, 1.1 parts of tricalcium phosphate, 0.085 part of potassium chloride, 0.045 part of magnesium hydrogen phosphate, 0.045 part of sodium chloride, 1.1 part of milk calcium, 1.1 part of ferrous sulfate, 1.1 part of zinc sulfate, 1 part of copper sulfate, 0.9 part of manganese sulfate, 1 part of potassium iodide, 0.085 part of sodium sulfite, 0.075 part of choline chloride, 0.085 part of L-ascorbic acid, 0.095 part of ascorbyl palmitate, 0.035 part of D-alpha-phenol acetate, 0.011 part of inositol, 1.1 part of D-calcium pantothenate, 0.65 part of 0665 part of riboflavin, 1.011 part of riboflavin, 0.011 part of ammonium chloride, 0.045 part of tolytate, 0.011 part of pyridoxine hydrochloride, 0.1.045 part of pyridoxine A, 1.1.011 part of vitamin A, 1.0.045 part of, Vitamin D31 parts, 1 part of docosahexaenoic acid oil ester, 1 part of arachidonic acid grease, 1.1 parts of taurine and 1.1 parts of edible essence.
Preferably, the milk powder comprises the following raw material components in parts by weight: 420 parts of whole milk powder, 6 parts of lactose, 1 part of colostrum basic protein, 1.2 parts of hydrolyzed yolk powder, 1.2 parts of soybean oil, 2.2 parts of fructo-oligosaccharide, 3.2 parts of galacto-oligosaccharide, 4 parts of bifidobacterium lactis, 0.06 part of maltodextrin, 12 parts of concentrated whey protein powder, 0.07 part of potassium citrate, 1.2 parts of tricalcium phosphate, 0.09 part of potassium chloride, 0.05 part of magnesium hydrogen phosphate, 0.05 part of sodium chloride, 1.2 parts of milk calcium, 1.2 parts of ferrous sulfate, 1.2 parts of zinc sulfate, 1.1 parts of copper sulfate, 1 part of manganese sulfate, 1.1 part of potassium iodide, 0.09 part of sodium sulfite, 0.08 part of choline chloride, 0.09 part of L-ascorbic acid, 0.1 part of ascorbyl palmitate, 0.04 part of D-alpha-tocopheryl acetate, 0.012 part of inositol, 1.2 parts of D-calcium pantothenate, 0.7 part of nicotinamide, 1 part of riboflavin, 0.012 part of ammonium nicotinate, 0.012 part of palmitic acid, 1.05 part of vitamin A, 0.05 part of pyridoxine hydrochloride, 0.07 part of pyridoxine hydrochloride, 0.05 part of pyridoxine, 31.1 parts of vitamin D, 1.1 parts of docosahexaenoic acid oil ester, 1.1 parts of arachidonic acid oil, 1.2 parts of taurine and 1.2 parts of edible essence.
The preparation method of the milk powder beneficial to promoting height development comprises the following steps:
s1, adding water into whole milk powder to dissolve, adding lactose, soybean oil, fructo-oligosaccharide, galacto-oligosaccharide, maltodextrin, concentrated whey protein powder, potassium citrate, tricalcium phosphate, potassium chloride, magnesium hydrogen phosphate, sodium chloride, milk calcium, ferrous sulfate, zinc sulfate, copper sulfate, manganese sulfate, potassium iodide, sodium sulfite, choline chloride, inositol, D-calcium pantothenate, nicotinamide, riboflavin, thiamine nicotinate, pyridoxine hydrochloride, folic acid and phytotoluquinone into the whole milk powder, homogenizing, and preparing a mixed solution;
s2, sterilizing the mixed solution prepared in the step S1 to prepare a sterilized mixed solution;
s3, vacuum concentrating the sterilized mixed solution prepared in the step S2 to 15-18 Baume degrees, and performing spray granulation to obtain mixed particles;
and S4, dry mixing the mixed particles prepared in the step S3 with colostrum basic protein, hydrolyzed yolk powder, bifidobacterium lactis, L-ascorbic acid, ascorbyl palmitate, D-alpha-tocopheryl acetate, vitamin A palmitate, vitamin D3, docosahexaenoic acid oil, arachidonic acid oil, taurine and edible essence to prepare the milk powder beneficial to promoting the height development.
Preferably, in step S1, the concentration of the solution is ensured to be less than 11 baume degree before homogenization; the homogenizing condition is that the homogenizing temperature is 40-50 ℃, and the homogenizing pressure is 10-18 Mpa;
preferably, in step S2, the sterilization is performed at 80-88 ℃ for 3 min.
Preferably, in step S3, the spray granulation conditions are a discharge temperature of 75-88 deg.C and a pressure of 10-18 MPa.
Effect of colostrum basic protein: colostrum basic protein (Colostrum basic protein) can promote osteoblast proliferation, greatly enhance the absorption and utilization of calcium and keep bone density; can directly act on bone cells to promote bone metabolism; can coordinate the activities of osteoblast and osteoclast, maintain the dynamic balance of osteoblast and osteoclast, promote the growth of bone, and repair bone.
Effect of hydrolyzed egg yolk powder: the hydrolyzed yolk powder is a functional substance extracted from egg yolk, and can promote the production of bone growth factors (IGF1 and TGF beta 1) by stimulating bone bud cells, thereby promoting the growth of bones; can maintain the balance of bone components by inhibiting the secretion of cell division factors (such as IL-1, IL-6, TNF alpha) of osteoclast; can promote calcium absorption, and inhibit excessive calcium loss, thereby promoting bone growth and health.
Effect of vitamin D3: vitamin D3 is also known as cholecalciferol, a type of vitamin D. Can improve the absorption of organism to calcium and phosphorus, and make the level of plasma calcium and plasma phosphorus reach saturation level; can promote growth and skeleton calcification, and promote tooth health; increased phosphorus absorption through the intestinal wall and increased phosphorus reabsorption through the renal tubules; is capable of maintaining normal levels of citrate in the blood; amino acid loss through the kidney can be prevented.
The function of milk calcium: the milk calcium can be separated to present an ionic state without the participation of too much gastric acid in a human body, and then can be directly absorbed and utilized by the human body, thereby quickly regulating the balance of blood and calcium and strengthening the physique. Milk calcium is recognized as a food grade calcium supplement with highest "bioavailability" of all calcium materials, because milk calcium also contains a proper amount of protein and a reasonable calcium-phosphorus ratio of 2: 1. Meanwhile, the production process does not have any chemical components and processes, so that the gastrointestinal tract is not burdened. Is suitable for supplementing calcium for infants, pregnant women, children, and the elderly. Can promote bone development, protect intestinal tract, and maintain acid-base balance in human body.
The invention has the beneficial effects that:
(1) the formula of the milk powder beneficial to promoting the height development provided by the invention is comprehensive in nutrition, and the colostrum basic protein, the hydrolyzed yolk powder, the vitamin D3 and the milk calcium are matched, so that the skeleton development of children is promoted comprehensively.
(2) The preparation method of the milk powder beneficial to promoting the height development adopts a dry-wet compounding process, the basic nutrition of children in the growth development is ensured by adding in a wet process, and some heat-sensitive nutrients are particularly added in a dry process, so that the loss of the activity of the nutritional ingredients of the milk powder is avoided.
Detailed Description
Hereinafter, embodiments of the present invention will be described in detail. The following examples are only for illustrating the technical solutions of the present invention more clearly, and therefore are only examples, and the protection scope of the present invention is not limited thereby.
It is to be noted that, unless otherwise specified, technical or scientific terms used herein shall have the ordinary meaning as understood by those skilled in the art to which the invention pertains.
Example 1
The milk powder beneficial to promoting height development comprises the following raw material components in parts by weight: 380 parts of whole milk powder, 4 parts of lactose, 0.6 part of colostrum basic protein, 0.8 part of hydrolyzed yolk powder, 0.8 part of soybean oil, 1.8 parts of fructo-oligosaccharide, 2.8 parts of galacto-oligosaccharide, 2 parts of bifidobacterium lactis, 0.04 part of maltodextrin, 8 parts of concentrated whey protein powder, 0.05 part of potassium citrate, 0.8 part of tricalcium phosphate, 0.07 part of potassium chloride, 0.03 part of magnesium hydrogen phosphate, 0.03 part of sodium chloride, 0.8 part of milk calcium, 0.8 part of ferrous sulfate, 0.8 part of zinc sulfate, 0.7 part of copper sulfate, 0.6 part of manganese sulfate, 0.7 part of potassium iodide, 0.07 part of sodium sulfite, 0.06 part of choline chloride, 0.07 part of L-ascorbic acid, 0.08 part of ascorbyl palmitate, 0.02 part of D-alpha-tocopheryl acetate, 0.008 part of inositol, 0.8 part of D-calcium pantothenate, 0.5 part of nicotinamide, 0.7 part of riboflavin, 0.008 part of ammonium nicotinate, 0.03 part of ammonium palmitate, 0.05 part of pyridoxine hydrochloride, 0.05 part of phytol, 30.7 parts of vitamin D, 0.7 part of docosahexaenoic acid oil ester, 0.7 part of arachidonic acid grease, 0.8 part of taurine and 0.8 part of edible essence.
The preparation method of the milk powder beneficial to promoting height development comprises the following steps:
s1, adding water into whole milk powder to dissolve, adding lactose, soybean oil, fructo-oligosaccharide, galacto-oligosaccharide, maltodextrin, concentrated whey protein powder, potassium citrate, tricalcium phosphate, potassium chloride, magnesium hydrogen phosphate, sodium chloride, milk calcium, ferrous sulfate, zinc sulfate, copper sulfate, manganese sulfate, potassium iodide, sodium sulfite, choline chloride, inositol, D-calcium pantothenate, nicotinamide, riboflavin, thiamine nicotinate, pyridoxine hydrochloride, folic acid and phytotoluquinone into the whole milk powder, homogenizing, and preparing a mixed solution;
s2, sterilizing the mixed solution prepared in the step S1 to prepare a sterilized mixed solution;
s3, vacuum concentrating the sterilized mixed solution prepared in the step S2 to 15-18 Baume degrees, and performing spray granulation to obtain mixed particles;
and S4, dry mixing the mixed particles prepared in the step S3 with colostrum basic protein, hydrolyzed yolk powder, bifidobacterium lactis, L-ascorbic acid, ascorbyl palmitate, D-alpha-tocopheryl acetate, vitamin A palmitate, vitamin D3, docosahexaenoic acid oil, arachidonic acid oil, taurine and edible essence to prepare the milk powder beneficial to promoting the height development.
In step S1, the solution concentration is ensured to be less than 11 baume degree before homogenization; the homogenizing condition is that the homogenizing temperature is 40-50 ℃, and the homogenizing pressure is 10-18 Mpa;
in step S2, the sterilization is performed at 85 ℃ for 3 min.
In step S3, the conditions of spray granulation are that the air exhaust temperature is 75-88 ℃ and the pressure is 10-18 Mpa.
Example 2
The milk powder beneficial to promoting height development comprises the following raw material components in parts by weight: 390 parts of whole milk powder, 4.5 parts of lactose, 0.7 part of colostrum basic protein, 0.9 part of hydrolyzed yolk powder, 0.9 part of soybean oil, 1.9 parts of fructo-oligosaccharide, 2.9 parts of galacto-oligosaccharide, 2.5 parts of bifidobacterium lactis, 0.045 part of maltodextrin, 9 parts of concentrated whey protein powder, 0.055 part of potassium citrate, 0.9 part of tricalcium phosphate, 0.075 part of potassium chloride, 0.035 part of magnesium hydrogen phosphate, 0.035 part of sodium chloride, 0.9 part of milk calcium, 0.9 part of ferrous sulfate, 0.9 part of zinc sulfate, 0.8 part of copper sulfate, 0.7 part of manganese sulfate, 0.8 part of potassium iodide, 0.075 part of sodium subsp, 0.065 part of choline chloride, 0.075 part of L-ascorbic acid, 0.085 part of ascorbyl palmitate, 0.025 part of D-alpha-phenol acetate, 0.009 part of inositol, 0.9 part of D-calcium pantothenate, 0.0655 part of riboflavin, 0.8 part of riboflavin, 0.009 part of picolinic acid, 0.009 part of pyridoxine, 0.009 part of vitamin A, 0.055 part of vitamin A, pyridoxine hydrochloride, 0.035 parts of pyridoxine hydrochloride, 0.055 part of vitamin A, 30.8 parts of vitamin D, 0.8 part of docosahexaenoic acid oil ester, 0.8 part of arachidonic acid grease, 0.9 part of taurine and 0.9 part of edible essence.
The preparation method of the milk powder beneficial to promoting height development comprises the following steps:
s1, adding water into whole milk powder to dissolve, adding lactose, soybean oil, fructo-oligosaccharide, galacto-oligosaccharide, maltodextrin, concentrated whey protein powder, potassium citrate, tricalcium phosphate, potassium chloride, magnesium hydrogen phosphate, sodium chloride, milk calcium, ferrous sulfate, zinc sulfate, copper sulfate, manganese sulfate, potassium iodide, sodium sulfite, choline chloride, inositol, D-calcium pantothenate, nicotinamide, riboflavin, thiamine nicotinate, pyridoxine hydrochloride, folic acid and phytotoluquinone into the whole milk powder, homogenizing, and preparing a mixed solution;
s2, sterilizing the mixed solution prepared in the step S1 to prepare a sterilized mixed solution;
s3, vacuum concentrating the sterilized mixed solution prepared in the step S2 to 15-18 Baume degrees, and performing spray granulation to obtain mixed particles;
and S4, dry mixing the mixed particles prepared in the step S3 with colostrum basic protein, hydrolyzed yolk powder, bifidobacterium lactis, L-ascorbic acid, ascorbyl palmitate, D-alpha-tocopheryl acetate, vitamin A palmitate, vitamin D3, docosahexaenoic acid oil, arachidonic acid oil, taurine and edible essence to prepare the milk powder beneficial to promoting the height development.
In step S1, the solution concentration is ensured to be less than 11 baume degree before homogenization; the homogenizing condition is that the homogenizing temperature is 40-50 ℃, and the homogenizing pressure is 10-18 Mpa;
in step S2, the sterilization is performed at 85 ℃ for 3 min.
In step S3, the conditions of spray granulation are that the air exhaust temperature is 75-88 ℃ and the pressure is 10-18 Mpa.
Example 3
The milk powder beneficial to promoting height development comprises the following raw material components in parts by weight: 400 parts of whole milk powder, 5 parts of lactose, 0.8 part of colostrum basic protein, 1 part of hydrolyzed yolk powder, 1 part of soybean oil, 2 parts of fructo-oligosaccharide, 3 parts of galacto-oligosaccharide, 3 parts of bifidobacterium lactis, 0.05 part of maltodextrin, 10 parts of concentrated whey protein powder, 0.06 part of potassium citrate, 1 part of tricalcium phosphate, 0.08 part of potassium chloride, 0.04 part of magnesium hydrogen phosphate, 0.04 part of sodium chloride, 1 part of milk calcium, 1 part of ferrous sulfate, 1 part of zinc sulfate, 0.9 part of copper sulfate, 0.8 part of manganese sulfate, 0.9 part of potassium iodide, 0.08 part of sodium sulfite, 0.07 part of choline chloride, 0.08 part of L-ascorbic acid, 0.09 part of ascorbyl palmitate, 0.03 part of D-alpha-acetic acid phenol, 0.01 part of inositol, 1 part of D-calcium pantothenate, 0.6 part of nicotinamide, 0.9 part of riboflavin, 0.01 part of thiamine, 0.06 part of vitamin A1 part of palmitic acid, 0.04 part of pyridoxine hydrochloride, 0.07 part of phytochrome nicotinate, 0.07 part of pyridoxine, 30.9 parts of vitamin D, 0.9 part of docosahexaenoic acid oil ester, 0.9 part of arachidonic acid oil, 1 part of taurine and 1 part of edible essence.
The preparation method of the milk powder beneficial to promoting height development comprises the following steps:
s1, adding water into whole milk powder to dissolve, adding lactose, soybean oil, fructo-oligosaccharide, galacto-oligosaccharide, maltodextrin, concentrated whey protein powder, potassium citrate, tricalcium phosphate, potassium chloride, magnesium hydrogen phosphate, sodium chloride, milk calcium, ferrous sulfate, zinc sulfate, copper sulfate, manganese sulfate, potassium iodide, sodium sulfite, choline chloride, inositol, D-calcium pantothenate, nicotinamide, riboflavin, thiamine nicotinate, pyridoxine hydrochloride, folic acid and phytotoluquinone into the whole milk powder, homogenizing, and preparing a mixed solution;
s2, sterilizing the mixed solution prepared in the step S1 to prepare a sterilized mixed solution;
s3, vacuum concentrating the sterilized mixed solution prepared in the step S2 to 15-18 Baume degrees, and performing spray granulation to obtain mixed particles;
and S4, dry mixing the mixed particles prepared in the step S3 with colostrum basic protein, hydrolyzed yolk powder, bifidobacterium lactis, L-ascorbic acid, ascorbyl palmitate, D-alpha-tocopheryl acetate, vitamin A palmitate, vitamin D3, docosahexaenoic acid oil, arachidonic acid oil, taurine and edible essence to prepare the milk powder beneficial to promoting the height development.
In step S1, the solution concentration is ensured to be less than 11 baume degree before homogenization; the homogenizing condition is that the homogenizing temperature is 40-50 ℃, and the homogenizing pressure is 10-18 Mpa;
in step S2, the sterilization is performed at 85 ℃ for 3 min.
In step S3, the conditions of spray granulation are that the air exhaust temperature is 75-88 ℃ and the pressure is 10-18 Mpa.
Example 4
The milk powder beneficial to promoting height development comprises the following raw material components in parts by weight: 410 parts of whole milk powder, 5.5 parts of lactose, 0.9 part of colostrum basic protein, 1.1 part of hydrolyzed yolk powder, 1.1 parts of soybean oil, 2.1 parts of fructo-oligosaccharide, 3.1 parts of galacto-oligosaccharide, 3.5 parts of bifidobacterium lactis, 0.055 part of maltodextrin, 11 parts of concentrated whey protein powder, 0.065 part of potassium citrate, 1.1 parts of tricalcium phosphate, 0.085 part of potassium chloride, 0.045 part of magnesium hydrogen phosphate, 0.045 part of sodium chloride, 1.1 part of milk calcium, 1.1 part of ferrous sulfate, 1.1 part of zinc sulfate, 1 part of copper sulfate, 0.9 part of manganese sulfate, 1 part of potassium iodide, 0.085 part of sodium sulfite, 0.075 part of choline chloride, 0.085 part of L-ascorbic acid, 0.095 part of ascorbyl palmitate, 0.035 part of D-alpha-phenol acetate, 0.011 part of inositol, 1.1 part of D-calcium pantothenate, 0.65 part of 0665 part of riboflavin, 1.011 part of riboflavin, 0.011 part of ammonium chloride, 0.045 part of tolytate, 0.011 part of pyridoxine hydrochloride, 0.1.045 part of pyridoxine A, 1.1.011 part of vitamin A, 1.0.045 part of, Vitamin D31 parts, 1 part of docosahexaenoic acid oil ester, 1 part of arachidonic acid grease, 1.1 parts of taurine and 1.1 parts of edible essence.
The preparation method of the milk powder beneficial to promoting height development comprises the following steps:
s1, adding water into whole milk powder to dissolve, adding lactose, soybean oil, fructo-oligosaccharide, galacto-oligosaccharide, maltodextrin, concentrated whey protein powder, potassium citrate, tricalcium phosphate, potassium chloride, magnesium hydrogen phosphate, sodium chloride, milk calcium, ferrous sulfate, zinc sulfate, copper sulfate, manganese sulfate, potassium iodide, sodium sulfite, choline chloride, inositol, D-calcium pantothenate, nicotinamide, riboflavin, thiamine nicotinate, pyridoxine hydrochloride, folic acid and phytotoluquinone into the whole milk powder, homogenizing, and preparing a mixed solution;
s2, sterilizing the mixed solution prepared in the step S1 to prepare a sterilized mixed solution;
s3, vacuum concentrating the sterilized mixed solution prepared in the step S2 to 15-18 Baume degrees, and performing spray granulation to obtain mixed particles;
and S4, dry mixing the mixed particles prepared in the step S3 with colostrum basic protein, hydrolyzed yolk powder, bifidobacterium lactis, L-ascorbic acid, ascorbyl palmitate, D-alpha-tocopheryl acetate, vitamin A palmitate, vitamin D3, docosahexaenoic acid oil, arachidonic acid oil, taurine and edible essence to prepare the milk powder beneficial to promoting the height development.
In step S1, the solution concentration is ensured to be less than 11 baume degree before homogenization; the homogenizing condition is that the homogenizing temperature is 40-50 ℃, and the homogenizing pressure is 10-18 Mpa;
in step S2, the sterilization is performed at 85 ℃ for 3 min.
In step S3, the conditions of spray granulation are that the air exhaust temperature is 75-88 ℃ and the pressure is 10-18 Mpa.
Example 5
The milk powder beneficial to promoting height development comprises the following raw material components in parts by weight: 420 parts of whole milk powder, 6 parts of lactose, 1 part of colostrum basic protein, 1.2 parts of hydrolyzed yolk powder, 1.2 parts of soybean oil, 2.2 parts of fructo-oligosaccharide, 3.2 parts of galacto-oligosaccharide, 4 parts of bifidobacterium lactis, 0.06 part of maltodextrin, 12 parts of concentrated whey protein powder, 0.07 part of potassium citrate, 1.2 parts of tricalcium phosphate, 0.09 part of potassium chloride, 0.05 part of magnesium hydrogen phosphate, 0.05 part of sodium chloride, 1.2 parts of milk calcium, 1.2 parts of ferrous sulfate, 1.2 parts of zinc sulfate, 1.1 parts of copper sulfate, 1 part of manganese sulfate, 1.1 part of potassium iodide, 0.09 part of sodium sulfite, 0.08 part of choline chloride, 0.09 part of L-ascorbic acid, 0.1 part of ascorbyl palmitate, 0.04 part of D-alpha-tocopheryl acetate, 0.012 part of inositol, 1.2 parts of D-calcium pantothenate, 0.7 part of nicotinamide, 1 part of riboflavin, 0.012 part of ammonium nicotinate, 0.012 part of palmitic acid, 1.05 part of vitamin A, 0.05 part of pyridoxine hydrochloride, 0.07 part of pyridoxine hydrochloride, 0.05 part of pyridoxine, 31.1 parts of vitamin D, 1.1 parts of docosahexaenoic acid oil ester, 1.1 parts of arachidonic acid oil, 1.2 parts of taurine and 1.2 parts of edible essence.
The preparation method of the milk powder beneficial to promoting height development comprises the following steps:
s1, adding water into whole milk powder to dissolve, adding lactose, soybean oil, fructo-oligosaccharide, galacto-oligosaccharide, maltodextrin, concentrated whey protein powder, potassium citrate, tricalcium phosphate, potassium chloride, magnesium hydrogen phosphate, sodium chloride, milk calcium, ferrous sulfate, zinc sulfate, copper sulfate, manganese sulfate, potassium iodide, sodium sulfite, choline chloride, inositol, D-calcium pantothenate, nicotinamide, riboflavin, thiamine nicotinate, pyridoxine hydrochloride, folic acid and phytotoluquinone into the whole milk powder, homogenizing, and preparing a mixed solution;
s2, sterilizing the mixed solution prepared in the step S1 to prepare a sterilized mixed solution;
s3, vacuum concentrating the sterilized mixed solution prepared in the step S2 to 15-18 Baume degrees, and performing spray granulation to obtain mixed particles;
and S4, dry mixing the mixed particles prepared in the step S3 with colostrum basic protein, hydrolyzed yolk powder, bifidobacterium lactis, L-ascorbic acid, ascorbyl palmitate, D-alpha-tocopheryl acetate, vitamin A palmitate, vitamin D3, docosahexaenoic acid oil, arachidonic acid oil, taurine and edible essence to prepare the milk powder beneficial to promoting the height development.
In step S1, the solution concentration is ensured to be less than 11 baume degree before homogenization; the homogenizing condition is that the homogenizing temperature is 40-50 ℃, and the homogenizing pressure is 10-18 Mpa;
in step S2, the sterilization is performed at 85 ℃ for 3 min.
In step S3, the conditions of spray granulation are that the air exhaust temperature is 75-88 ℃ and the pressure is 10-18 Mpa.
Test examples
The milk powder beneficial to promoting the growth of height prepared in example 3 was taken, the nutritional components in the milk powder were measured, and the specific results are shown in Table 1
TABLE 1
| Item | Each 100 g | NVR％ |
| Energy of | 1912KJ | 23％ |
| Protein | 15 g | 25％ |
| Fat | 18 g | 30％ |
| Linoleic acid | 4 g | |
| Carbohydrate compound | 60 g | 20％ |
| Vitamin A | 480 microgram | 60％ |
| Vitamin D | 100 microgram | 200％ |
| Vitamin E | 8 mg of | 60％ |
| Vitamin K1 | 40 microgram | 50％ |
| Vitamin B1 | 1.0 mg | 70％ |
| Vitamin B2 | 1.0 mg | 70％ |
| Vitamin B6 | 0.5 mg | 36％ |
| Vitamin B12 | 1.8 microgram | 75％ |
| Nicotinic acid | 4.0 mg | 29％ |
| Folic acid | 120 microgram of | 30％ |
| Pantothenic acid | 3.0 microgram | 60％ |
| Vitamin C | 60 mg of | 60％ |
| Sodium salt | 176 mg of | 8％ |
| Potassium salt | 600 mg of | 30％ |
| Copper (Cu) | 0.5 mg | 30％ |
| Magnesium alloy | 100 mg of | 33％ |
| Iron | 10 mg of | 67％ |
| Zinc | 10 mg of | 67％ |
| Manganese oxide | 0.8 mg | 27％ |
| Calcium carbonate | 1980 mg | 248％ |
| Phosphorus (P) | 390 mg of | 56％ |
| Iodine | 50 microgram | 33％ |
| Selenium | 15 microgram of | 30％ |
| Choline | 110 mg of | 24％ |
| Biotin | 10 mg of | 33％ |
| Taurine | 40 mg of | |
| Didodecahexamine acid oil ester | 30 mg of | |
| Tetra-dilute acid of peanut | 30 mg of | |
| Xanthophyll | 200 microgram | |
| Growth factor | 100 mg of | |
| Hydrolyzed egg yolk powder | 1000 mg of |
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; such modifications and substitutions do not depart from the spirit and scope of the present invention, and they should be construed as being included in the following claims and description.
Claims (10)
1. A milk powder beneficial to promoting height development, which is characterized in that: the milk powder comprises the following raw material components in parts by weight: 380 portions of whole milk powder, 420 portions of milk powder, 4 to 6 portions of lactose, 0.6 to 1 portion of colostrum basic protein, 0.8 to 1.2 portions of hydrolyzed yolk powder, 0.8 to 1.2 portions of soybean oil, 1.8 to 2.2 portions of fructo-oligosaccharide, 2.8 to 3.2 portions of galacto-oligosaccharide, 2 to 4 portions of bifidobacterium lactis, 0.04 to 0.06 portion of maltodextrin, 8 to 12 portions of concentrated whey protein powder, 0.05 to 0.07 portion of potassium citrate, 0.8 to 1.2 portions of tricalcium phosphate, 0.07 to 0.09 portion of potassium chloride, 0.03 to 0.05 portion of magnesium hydrogen phosphate, 0.03 to 0.05 portion of sodium chloride, 0.8 to 1.2 portions of milk calcium, 0.8 to 1.2 portion of ferrous sulfate, 0.8 to 1.2 portions of zinc sulfate, 0.7 to 1.1 portion of copper sulfate, 0.6 to 1 portion of manganese sulfate, 0.7 to 1 portion of potassium iodide, 0.7 to 1.1 portion of sodium chlorite, 0.07 to 0.06 portion of sodium chlorite, 0.09 to 0.07 portion of L-1 portion of L-L, 0.08-0.10 part of ascorbyl palmitate, 0.02-0.04 part of D-alpha-tocopherol acetate, 0.008-0.012 part of inositol, 0.8-1.2 part of D-calcium pantothenate, 0.5-0.7 part of nicotinamide, 0.7-1.1 part of riboflavin, 0.008-0.012 part of ammonium nicotinate sulfate, 0.8-1.2 part of vitamin A palmitate, 0.03-0.05 part of pyridoxine hydrochloride, 0.05-0.07 part of folic acid, 0.06-0.08 part of phytotoluquinone, 30.7-1.1 part of vitamin D, 0.7-1.1 part of docosahexaenoic acid oil ester, 0.7-1.1 part of peanut tetraol, 0.8-1.2 part of taurine and 0.8-1.2 part of edible essence.
2. Milk powder beneficial for promoting height development according to claim 1, characterized in that: the milk powder comprises the following raw material components in parts by weight: 380 parts of whole milk powder, 4 parts of lactose, 0.6 part of colostrum basic protein, 0.8 part of hydrolyzed yolk powder, 0.8 part of soybean oil, 1.8 parts of fructo-oligosaccharide, 2.8 parts of galacto-oligosaccharide, 2 parts of bifidobacterium lactis, 0.04 part of maltodextrin, 8 parts of concentrated whey protein powder, 0.05 part of potassium citrate, 0.8 part of tricalcium phosphate, 0.07 part of potassium chloride, 0.03 part of magnesium hydrogen phosphate, 0.03 part of sodium chloride, 0.8 part of milk calcium, 0.8 part of ferrous sulfate, 0.8 part of zinc sulfate, 0.7 part of copper sulfate, 0.6 part of manganese sulfate, 0.7 part of potassium iodide, 0.07 part of sodium sulfite, 0.06 part of choline chloride, 0.07 part of L-ascorbic acid, 0.08 part of ascorbyl palmitate, 0.02 part of D-alpha-tocopheryl acetate, 0.008 part of inositol, 0.8 part of D-calcium pantothenate, 0.5 part of nicotinamide, 0.7 part of riboflavin, 0.008 part of ammonium nicotinate, 0.03 part of ammonium palmitate, 0.05 part of pyridoxine hydrochloride, 0.05 part of phytol, 30.7 parts of vitamin D, 0.7 part of docosahexaenoic acid oil ester, 0.7 part of arachidonic acid grease, 0.8 part of taurine and 0.8 part of edible essence.
3. Milk powder beneficial for promoting height development according to claim 1, characterized in that: the milk powder comprises the following raw material components in parts by weight: 390 parts of whole milk powder, 4.5 parts of lactose, 0.7 part of colostrum basic protein, 0.9 part of hydrolyzed yolk powder, 0.9 part of soybean oil, 1.9 parts of fructo-oligosaccharide, 2.9 parts of galacto-oligosaccharide, 2.5 parts of bifidobacterium lactis, 0.045 part of maltodextrin, 9 parts of concentrated whey protein powder, 0.055 part of potassium citrate, 0.9 part of tricalcium phosphate, 0.075 part of potassium chloride, 0.035 part of magnesium hydrogen phosphate, 0.035 part of sodium chloride, 0.9 part of milk calcium, 0.9 part of ferrous sulfate, 0.9 part of zinc sulfate, 0.8 part of copper sulfate, 0.7 part of manganese sulfate, 0.8 part of potassium iodide, 0.075 part of sodium subsp, 0.065 part of choline chloride, 0.075 part of L-ascorbic acid, 0.085 part of ascorbyl palmitate, 0.025 part of D-alpha-phenol acetate, 0.009 part of inositol, 0.9 part of D-calcium pantothenate, 0.0655 part of riboflavin, 0.8 part of riboflavin, 0.009 part of picolinic acid, 0.009 part of pyridoxine, 0.009 part of vitamin A, 0.055 part of vitamin A, pyridoxine hydrochloride, 0.035 parts of pyridoxine hydrochloride, 0.055 part of vitamin A, 30.8 parts of vitamin D, 0.8 part of docosahexaenoic acid oil ester, 0.8 part of arachidonic acid grease, 0.9 part of taurine and 0.9 part of edible essence.
4. Milk powder beneficial for promoting height development according to claim 1, characterized in that: the milk powder comprises the following raw material components in parts by weight: 400 parts of whole milk powder, 5 parts of lactose, 0.8 part of colostrum basic protein, 1 part of hydrolyzed yolk powder, 1 part of soybean oil, 2 parts of fructo-oligosaccharide, 3 parts of galacto-oligosaccharide, 3 parts of bifidobacterium lactis, 0.05 part of maltodextrin, 10 parts of concentrated whey protein powder, 0.06 part of potassium citrate, 1 part of tricalcium phosphate, 0.08 part of potassium chloride, 0.04 part of magnesium hydrogen phosphate, 0.04 part of sodium chloride, 1 part of milk calcium, 1 part of ferrous sulfate, 1 part of zinc sulfate, 0.9 part of copper sulfate, 0.8 part of manganese sulfate, 0.9 part of potassium iodide, 0.08 part of sodium sulfite, 0.07 part of choline chloride, 0.08 part of L-ascorbic acid, 0.09 part of ascorbyl palmitate, 0.03 part of D-alpha-acetic acid phenol, 0.01 part of inositol, 1 part of D-calcium pantothenate, 0.6 part of nicotinamide, 0.9 part of riboflavin, 0.01 part of thiamine, 0.06 part of vitamin A1 part of palmitic acid, 0.04 part of pyridoxine hydrochloride, 0.07 part of phytochrome nicotinate, 0.07 part of pyridoxine, 30.9 parts of vitamin D, 0.9 part of docosahexaenoic acid oil ester, 0.9 part of arachidonic acid oil, 1 part of taurine and 1 part of edible essence.
5. Milk powder beneficial for promoting height development according to claim 1, characterized in that: the milk powder comprises the following raw material components in parts by weight: 410 parts of whole milk powder, 5.5 parts of lactose, 0.9 part of colostrum basic protein, 1.1 part of hydrolyzed yolk powder, 1.1 parts of soybean oil, 2.1 parts of fructo-oligosaccharide, 3.1 parts of galacto-oligosaccharide, 3.5 parts of bifidobacterium lactis, 0.055 part of maltodextrin, 11 parts of concentrated whey protein powder, 0.065 part of potassium citrate, 1.1 parts of tricalcium phosphate, 0.085 part of potassium chloride, 0.045 part of magnesium hydrogen phosphate, 0.045 part of sodium chloride, 1.1 part of milk calcium, 1.1 part of ferrous sulfate, 1.1 part of zinc sulfate, 1 part of copper sulfate, 0.9 part of manganese sulfate, 1 part of potassium iodide, 0.085 part of sodium sulfite, 0.075 part of choline chloride, 0.085 part of L-ascorbic acid, 0.095 part of ascorbyl palmitate, 0.035 part of D-alpha-phenol acetate, 0.011 part of inositol, 1.1 part of D-calcium pantothenate, 0.65 part of 0665 part of riboflavin, 1.011 part of riboflavin, 0.011 part of ammonium chloride, 0.045 part of tolytate, 0.011 part of pyridoxine hydrochloride, 0.1.045 part of pyridoxine A, 1.1.011 part of vitamin A, 1.0.045 part of, Vitamin D31 parts, 1 part of docosahexaenoic acid oil ester, 1 part of arachidonic acid grease, 1.1 parts of taurine and 1.1 parts of edible essence.
6. Milk powder beneficial for promoting height development according to claim 1, characterized in that: the milk powder comprises the following raw material components in parts by weight: 420 parts of whole milk powder, 6 parts of lactose, 1 part of colostrum basic protein, 1.2 parts of hydrolyzed yolk powder, 1.2 parts of soybean oil, 2.2 parts of fructo-oligosaccharide, 3.2 parts of galacto-oligosaccharide, 4 parts of bifidobacterium lactis, 0.06 part of maltodextrin, 12 parts of concentrated whey protein powder, 0.07 part of potassium citrate, 1.2 parts of tricalcium phosphate, 0.09 part of potassium chloride, 0.05 part of magnesium hydrogen phosphate, 0.05 part of sodium chloride, 1.2 parts of milk calcium, 1.2 parts of ferrous sulfate, 1.2 parts of zinc sulfate, 1.1 parts of copper sulfate, 1 part of manganese sulfate, 1.1 part of potassium iodide, 0.09 part of sodium sulfite, 0.08 part of choline chloride, 0.09 part of L-ascorbic acid, 0.1 part of ascorbyl palmitate, 0.04 part of D-alpha-tocopheryl acetate, 0.012 part of inositol, 1.2 parts of D-calcium pantothenate, 0.7 part of nicotinamide, 1 part of riboflavin, 0.012 part of ammonium nicotinate, 0.012 part of palmitic acid, 1.05 part of vitamin A, 0.05 part of pyridoxine hydrochloride, 0.07 part of pyridoxine hydrochloride, 0.05 part of pyridoxine, 31.1 parts of vitamin D, 1.1 parts of docosahexaenoic acid oil ester, 1.1 parts of arachidonic acid oil, 1.2 parts of taurine and 1.2 parts of edible essence.
7. A method of producing a milk powder beneficial for promoting height development according to any one of claims 1 to 6, wherein: the preparation method comprises the following steps: s1, adding water into whole milk powder to dissolve, adding lactose, soybean oil, fructo-oligosaccharide, galacto-oligosaccharide, maltodextrin, concentrated whey protein powder, potassium citrate, tricalcium phosphate, potassium chloride, magnesium hydrogen phosphate, sodium chloride, milk calcium, ferrous sulfate, zinc sulfate, copper sulfate, manganese sulfate, potassium iodide, sodium sulfite, choline chloride, inositol, D-calcium pantothenate, nicotinamide, riboflavin, thiamine nicotinate, pyridoxine hydrochloride, folic acid and phytotoluquinone into the whole milk powder, homogenizing, and preparing a mixed solution; s2, sterilizing the mixed solution prepared in the step S1 to prepare a sterilized mixed solution; s3, vacuum concentrating the sterilized mixed solution prepared in the step S2 to 15-18 Baume degrees, and performing spray granulation to obtain mixed particles; and S4, dry mixing the mixed particles prepared in the step S3 with colostrum basic protein, hydrolyzed yolk powder, bifidobacterium lactis, L-ascorbic acid, ascorbyl palmitate, D-alpha-tocopheryl acetate, vitamin A palmitate, vitamin D3, docosahexaenoic acid oil, arachidonic acid oil, taurine and edible essence to prepare the milk powder beneficial to promoting the height development.
8. The method for preparing milk powder beneficial to promoting height development according to claim 7, wherein: in step S1, the solution concentration is ensured to be less than 11 baume degree before homogenization; the homogenizing condition is that the homogenizing temperature is 40-50 ℃, and the homogenizing pressure is 10-18 Mpa.
9. The method for preparing milk powder beneficial to promoting height development according to claim 7, wherein: in step S2, the sterilization is performed at 80-88 deg.C for 3 min.
10. The method for preparing milk powder beneficial to promoting height development according to claim 7, wherein: in step S3, the conditions of spray granulation are that the air exhaust temperature is 75-88 ℃ and the pressure is 10-18 Mpa.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010657603.4A CN111758781A (en) | 2020-07-09 | 2020-07-09 | Milk powder beneficial to promoting height development and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010657603.4A CN111758781A (en) | 2020-07-09 | 2020-07-09 | Milk powder beneficial to promoting height development and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111758781A true CN111758781A (en) | 2020-10-13 |
Family
ID=72725869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010657603.4A Pending CN111758781A (en) | 2020-07-09 | 2020-07-09 | Milk powder beneficial to promoting height development and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111758781A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112889929A (en) * | 2021-02-26 | 2021-06-04 | 广州麦乐生物科技有限公司 | Preparation method and formula of milk powder for promoting height development of children |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110786388A (en) * | 2019-11-29 | 2020-02-14 | 成都桥然生物科技有限公司 | Milk powder for promoting growth of children and preparation method thereof |
| CN111374183A (en) * | 2020-03-23 | 2020-07-07 | 江西功夫熊实业有限公司 | Formula milk powder for promoting growth and development of children height |
-
2020
- 2020-07-09 CN CN202010657603.4A patent/CN111758781A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110786388A (en) * | 2019-11-29 | 2020-02-14 | 成都桥然生物科技有限公司 | Milk powder for promoting growth of children and preparation method thereof |
| CN111374183A (en) * | 2020-03-23 | 2020-07-07 | 江西功夫熊实业有限公司 | Formula milk powder for promoting growth and development of children height |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112889929A (en) * | 2021-02-26 | 2021-06-04 | 广州麦乐生物科技有限公司 | Preparation method and formula of milk powder for promoting height development of children |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105053217A (en) | Infant formula ewe milk powder and production method thereof | |
| CN113397164A (en) | Special medical full-nutrition formula food for improving immunity and preparation method thereof | |
| CN104920618A (en) | Formula goat milk powder for pregnant and lying-in woman | |
| CN111387487A (en) | Special medical use formula nutrition powder for lung disease patients and preparation method thereof | |
| US20100292194A1 (en) | Formulas comprising highly soluble elements and vitamins for the prevention and amelioration of osteoporosis | |
| CN111165801A (en) | Medical nutrition powder for osteopathic rehabilitation patients and preparation method thereof | |
| CN108477622A (en) | A kind of infant's global function alimentation composition | |
| CN112772722A (en) | Formula and production method of milk powder for helping skeleton and height development of children | |
| CN113632848A (en) | Children milk powder beneficial to bone growth and preparation method thereof | |
| CN111758781A (en) | Milk powder beneficial to promoting height development and preparation method thereof | |
| KR20120083680A (en) | Method of manufacturing stable and high concentration calcium phosphate aqueous solutions in neutral ph range | |
| CN110637888A (en) | Preterm/low birth weight infant formula powder and preparation method thereof | |
| CN113841740A (en) | Sialic acid-containing infant formula milk powder and preparation method thereof | |
| CN107105738A (en) | Infant nutrition containing aminosal, ionized calcium and palmitic acid | |
| CN111642566A (en) | Goat milk powder beneficial to children's height and intelligence development | |
| CN111165802A (en) | Medical nutrition powder for kidney disease non-dialysis patients and preparation method thereof | |
| CN108741103A (en) | A kind of flu phase small peptide formula powder of strengthen immunity and preparation method thereof | |
| WO2018154530A1 (en) | Composition or medical food to extract the dietary iron and boost its bioavailability for iron deficiency (id) and id-anemia | |
| CN114431304A (en) | A second-stage infant formula milk powder with donkey milk as base material and its preparation method | |
| CN114946955A (en) | Milk powder for promoting bone growth and intelligence development and brain strengthening and preparation method thereof | |
| CN110742266B (en) | Total nutrient formula food for assisting in regulating intestinal immunity function | |
| CN113412936A (en) | Enteral nutrition preparation for sarcopenia patients | |
| CN113647462A (en) | Formula and preparation method of lactobacillus child modified milk powder | |
| CN111387485A (en) | Medical nutrition powder for chronic pancreatitis patients and preparation method thereof | |
| CN110214939A (en) | Special medicine purposes formula nutritional powder and preparation method thereof for crowd after performing the operation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201013 |